Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Manufacturing Press Releases.
Press releases published on June 2, 2025

Plexus Issues Fiscal 2024 Sustainability Report
NEENAH, Wis., June 02, 2025 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today released its fiscal 2024 Sustainability Report. The report, which is now available on the company’s Sustainability web page, highlights how Plexus’ commitment to …

JTS Opens Second Idaho Facility, Creating 140 New Jobs and Expanding U.S. Manufacturing Footprint
NAMPA, Idaho and MCKINNEY, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- JTS, a Mission Critical Group (MCG) Company, today announced the opening of a new 172,000-square-foot advanced manufacturing facility on 14 acres in Nampa, Idaho, known as JTS Nampa 1. The …

Pasithea Therapeutics Presents Updated Interim Data from Ongoing Phase 1 Study of PAS-004 at the ASCO Annual Meeting 2025
-- PAS-004 demonstrates preliminary clinical activity as a monotherapy in patients with heavily pre-treated, refractory solid tumors -- -- One patient in cohort 4A (15mg capsule) with stage 4 BRAF-mutated melanoma, who had progressed after two prior lines …

Trust Wallet Launches Buy+, Powered by Binance Connect, to Simplify Crypto Access
Users can buy tokens on BNB Chain, Base and Solana directly with cards, local currency and more - all without leaving the Trust Wallet app. DUBAI, United Arab Emirates, June 02, 2025 (GLOBE NEWSWIRE) -- Trust Wallet, the world’s leading self-custody Web3 …

Confluent Health Releases Groundbreaking Documentary to Tackle America’s Chronic Pain Crisis
LOUISVILLE, Ky., June 02, 2025 (GLOBE NEWSWIRE) -- What if everything we thought we knew about pain was wrong? Today, more than 1 in 5 Americans live with chronic pain, and too often, their pain is met with silence, surgery, or a prescription pad. Now, …

Esperion Reaches Settlement Agreement with Second ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040
ANN ARBOR, Mich., June 02, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Hetero USA, Inc. and its affiliates Hetero Labs Limited, Hetero Labs Limited Unit-V, and Honour Lab Limited ( …

Applied Digital Announces 250MW AI Data Center Lease With CoreWeave in North Dakota
DALLAS, June 02, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD), a designer, builder and operator of next-generation digital infrastructure for HPC applications, has entered into two approximately 15-year lease agreements with …

Aqua Metals Announces Allowance of Foundational U.S. Patent for Lithium Battery Recycling Technology
RENO, Nev., June 02, 2025 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a leader in sustainable lithium battery recycling, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent …

Lightbridge Completes Final Experiment Design for Designated ATR Core Position
RESTON, Va., June 02, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation (Nasdaq: LTBR), a leader in advanced nuclear fuel technology, today announced the completion of the final design review for its upcoming irradiation experiment, marking a critical step …

FDA Accepts TransCon® CNP NDA for Priority Review
– Once-weekly TransCon CNP demonstrated significantly higher annualized growth velocity, the primary endpoint, compared to placebo – Multiple benefits beyond linear growth were observed compared to placebo, with a safety and tolerability profile similar to …

Papa Johns Canada Introduces Cheddar Crust Pizza, A New Take on a Classic Favourite
EDMONTON, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- There’s a new reason to get excited about pizza night in Canada. Papa Johns is turning up the flavour with its latest menu addition: Cheddar Crust Pizza — a golden, cheesy twist on the classic crust fans …

Southern Realty Trust Expands Revolving Credit Facility to $100 Million with Addition of EverBank as Joint Lead Arranger
WEST PALM BEACH, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Southern Realty Trust Inc. (“SRT” or the “Company”), a lender on the TCG Real Estate platform, today announced the expansion of its senior secured revolving credit facility (the “Credit Facility”) …

Zefiro Publishes Whitepaper for its Lifecycle Solution Suite of Environmental Technologies
The Zefiro Lifecycle Solution (ZLS) leverages artificial intelligence for advanced modelling and analytics of well selection, leak profiling, environmental attributes, and abatement techniques. It offers an easy-to-use dashboard showing methane leak …

Sanborn Achieves SOC 2 Type 2 Attestation, Reinforcing Commitment to Data Security and Operational Integrity
COLORADO SPRINGS, Colo., June 02, 2025 (GLOBE NEWSWIRE) -- The Sanborn Map Company, Inc. (Sanborn), a leader in geospatial solutions and data services, is proud to announce that it has successfully completed a SOC 2 Type 2 audit. This independent …

SAP positioned as the Leader in the 2025 SPARK Matrix: Digital Twin of an Organization Solution by QKS Group
Middleton, Massachusetts, June 02, 2025 (GLOBE NEWSWIRE) -- The QKS Group SPARK Matrix™ provides competitive analysis and ranking of the leading Digital Twin of an Organization Solution vendors. SAP, with its comprehensive technology for the Digital Twin …

uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
~ Alignment with FDA continues to support Accelerated Approval pathway ~ ~ BLA submission planned for first quarter of 2026 ~ ~ Conference call today at 8:30 a.m. ET ~ LEXINGTON, Mass. and AMSTERDAM, June 02, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: …

BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology
RESEARCH TRIANGLE PARK, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that new data on oral, once-daily ORLADEYO® (berotralstat) for the prophylactic treatment of hereditary angioedema (HAE) will be …

Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025
Updated interim data remain consistent, showing 10.3-month median PFS overall and 11.0-month median PFS in 2L patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer Data continue to support planned initiation of pivotal study in mid-2025 Next- …

Outlook Therapeutics® Announces Commercial Launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK for the Treatment of Wet AMD
LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK) 2.8 million injections of repackaged off-label bevacizumab in Europe each year1 ISELIN, N.J., …

Recludix Pharma Announces Development Candidate Nomination of First-in-Class Oral STAT6 Inhibitor for Inflammatory Diseases and Achievement of Significant Milestone Under Collaboration with Sanofi
--Completion of GLP toxicology studies associated with a $50 million payment to Recludix under the collaboration with Sanofi -- REX-8756 is a potent and selective oral STAT6 inhibitor that demonstrates complete pathway inhibition and is well tolerated in …